Physician Assistant, Medical · Augusta, GA
NPI
1245530989
Since 2010
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2283 Wrightsboro Rd
Augusta, GA, 30904
Phone (706) 733-3373
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,759 services
Medicare patients, 2024
454
Average age 75
Drug cost, 2024
$1.6M
969 prescriptions
Company payments, 2025
$406
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashley C Wyatt Wells was code 99213 (office e&m - established), 367 times for 240 patients. In total Ashley C Wyatt Wells billed 1,759 services in 35 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 367 | 240 | $47.64 | $17K |
| 17003 Destruction Skin Lesion | Office | 315 | 76 | $3.39 | $1,068 |
| 99214 Office E&M - Established | Office | 271 | 179 | $69.49 | $19K |
| 17000 Destruction Skin Lesion | Office | 171 | 130 | $30.53 | $5,221 |
| 11102 Skin Biopsy | Office | 112 | 94 | $49.64 | $5,559 |
| 99212 Office E&M - Established | Office | 111 | 93 | $27.65 | $3,069 |
| 17110 Destruction Skin Lesion | Office | 99 | 70 | $57.58 | $5,701 |
| 99203 Office E&M - New | Office | 55 | 55 | $45.26 | $2,489 |
| 11103 Skin Biopsy | Office | 42 | 25 | $29.58 | $1,242 |
| 99204 Office E&M - New | Office | 39 | 39 | $76.73 | $2,993 |
| 36415 Venipuncture Blood Collection | Office | 28 | 21 | $6.45 | $181 |
| 99202 Office E&M - New | Office | 11 | 11 | $19.92 | $219 |
By year: 2022 $82K for 2,041 services; 2023 $86K for 1,945 services; 2024 $76K for 1,759 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 21 | $6.45 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Ashley C Wyatt Wells prescribed most often to Medicare patients was Triamcinolone Acetonide, with 129 prescriptions and refills. In total Ashley C Wyatt Wells wrote 969 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 129 | 143 | 65 | $1,614 |
| Ketoconazole Generic | 122 | 135 | 54 | $1,662 |
| Doxycycline Hyclate Generic | 92 | 95 | 43 | $1,486 |
| Clobetasol Propionate Generic | 61 | 62 | 39 | $1,867 |
| Hydrocortisone Generic | 56 | 58 | 25 | $312 |
| Ammonium Lactate Generic | 46 | 58 | 28 | $757 |
| Dupixent Pen Dupilumab | 42 | 42 | Under 11 | $175K |
| Fluocinonide Generic | 32 | 36 | 13 | $1,314 |
| Mupirocin Generic | 30 | 30 | 20 | $211 |
| Skyrizi Risankizumab-Rzaa | 25 | 68 | Under 11 | $531K |
| Clindamycin Phosphate Generic | 24 | 25 | Under 11 | $620 |
| Tremfya Guselkumab | 20 | 37 | Under 11 | $271K |
| Otezla Apremilast | 19 | 21 | Under 11 | $85K |
| Metronidazole Generic | 18 | 18 | Under 11 | $1,012 |
| Fluconazole Generic | 18 | 18 | 14 | $97.08 |
Brand drugs: 178 claims; generic drugs: 791 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashley C Wyatt Wells $406 ($406 in general payments such as food, travel and fees) from 11 companies. The largest payer was Novartis Pharmaceuticals Corporation with $87.62.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 3 | $87.62 |
| Pfizer Inc. PFE | 3 | $59.64 |
| Genzyme Corporation SNY | 2 | $43.35 |
| Lilly USA, LLC LLY | 2 | $37.09 |
| Abbvie Inc. ABBV | 2 | $37.04 |
| Organon LLC OGN | 1 | $35 |
| Mayne Pharma Commercial LLC | 2 | $23.26 |
| Janssen Biotech, Inc. JNJ | 1 | $22.46 |
| LEO Pharma Inc. | 1 | $21.95 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $19.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.